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Abstract 30 
Recent studies suggest that chemokines may mediate the luteolytic action of PGF2α (PGF).  31 
Our objective was to identify chemokines induced by PGF in vivo and to determine the effects of 32 
IL8 on specific luteal cell types in vitro.  Midcycle cows were injected with saline or PGF, ovaries 33 
were removed after 0.5 - 4 h and chemokine expression was analyzed by qPCR.  In vitro 34 
expression of IL8 was analyzed after PGF administration and with cell signaling inhibitors to 35 
determine the mechanism of PGF-induced chemokine expression.  Purified neutrophils were 36 
analyzed for migration and activation in response to IL8 and PGF.  Purified luteal cell types 37 
(steroidogenic, endothelial and fibroblast cells) were used to identify which cells respond to 38 
chemokines.  Neutrophils and peripheral blood mononuclear cells (PBMCs) were co-cultured 39 
with steroidogenic cells to determine their effect on progesterone production.  IL8, CXCL2, 40 
CCL2, and CCL8 transcripts were rapidly increased following PGF treatment in vivo and. The 41 
stimulatory action of PGF on IL8 mRNA expression in vitro was prevented by inhibition of p38 42 
and JNK signaling.  IL8, but not PGF, TNF, or TGFB1, stimulated neutrophil migration.  IL8 had 43 
no apparent action in purified luteal steroidogenic, endothelial, or fibroblast cells, but IL8 44 
stimulated ERK phosphorylation in neutrophils.  In co-culture experiments neither IL8 nor 45 
activated neutrophils altered basal or LH-stimulated luteal cell progesterone synthesis.  In 46 
contrast, activated PBMCs inhibited LH-stimulated progesterone synthesis from cultured luteal 47 
cells.  These data implicate a complex cascade of events during luteolysis involving chemokine 48 
signaling, neutrophil recruitment, and immune cell action within the corpus luteum.  49 
50 
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The corpus luteum develops after ovulation and secretes progesterone, a steroid hormone 53 
essential for the establishment and maintenance of early pregnancy (Niswender et al. 2000,  54 
Stocco et al. 2007).  In the absence of hormonal cues or pregnancy the corpus luteum will 55 
regress in a process termed luteolysis.  In many species, luteolysis is mediated by uterine 56 
and/or intraluteal release of prostaglandin F2 alpha (PGF) (Davis & Rueda 2002,  Wiltbank & 57 
Ottobre 2003,  Niswender et al. 2007,  Bogan et al. 2008).  PGF has been shown to act 58 
indirectly at the vascular level to cause disruption of luteal capillaries (Maroni & Davis 2011) and 59 
apoptosis of capillary endothelial cells (Henkes et al. 2008).  PGF has also been implicated in 60 
the initiation of luteal cell apoptosis in vivo (Davis & Rueda 2002,  Quirk et al. 2013); however, 61 
PGF alone cannot directly reduce the viability of luteal cells in vitro (Davis & Rueda 2002,  62 
Kawaguchi et al. 2013).  Thus, other mechanisms must be activated for luteolysis to proceed 63 
through both the functional (loss of progesterone secretion) and structural (apoptosis and tissue 64 
remodeling) stages of regression. 65 
 66 
Immune cells and their effector cytokines participate in various reproductive processes (Pate & 67 
Landis Keyes 2001,  Skarzynski 2008,  Shirasuna et al. 2012a, 2012b) including: ovulation 68 
(Vinatier et al. 1995,  Ujioka et al. 1998), endometrial function (Braundmeier et al. 2012,  Care et 69 
al. 2013), as well as corpus luteum formation and regression (Erlebacher et al. 2004,  70 
Skarzynski 2008,  Shirasuna et al. 2012a, 2012b, 2012c,  Care et al. 2013).  Interleukin 8 (IL8, 71 
also known as CXCL8) is a known chemotactic cytokine secreted by a variety of cells in 72 
response to inflammatory stimuli.  IL8 secretion is implicated in the recruitment and activation of 73 
neutrophils (Mukaida 2000, 2003), including within the corpus luteum (Polec et al. 2009,  74 
Jiemtaweeboon et al. 2011,  Shirasuna et al. 2012a).  In rabbits, neutralization of IL8 75 
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suppresses neutrophil activation and ovulation (Ujioka et al. 1998).  Recent studies also indicate 76 
that neutrophils and IL8 are involved in establishment of the corpus luteum following ovulation.  77 
IL8 and neutrophils are known to promote angiogenesis (Heidemann et al. 2003,  Li et al. 2003) 78 
findings which have been recently extended to the developing corpus luteum (Jiemtaweeboon 79 
et al. 2011,  Nitta et al. 2011,  Shirasuna et al. 2012b, 2012c).  IL8 is also capable of stimulating 80 
progesterone secretion by luteinizing granulosa (Shimizu et al. 2012) and theca cells (Shimizu 81 
et al. 2013). 82 
 83 
Our objective was to identify chemokines induced by PGF in vivo and to determine the effect of 84 
IL8 on specific luteal cell types in vitro. We also employed co-cultures to evaluate the effects of 85 
immune cells on luteal progesterone synthesis. The present study demonstrates that PGF 86 
stimulates the expression of IL8, CCL8, CCL2 and CXCL2. While IL8 was effective at 87 
recruitment of neutrophils, neither IL8 nor activated neutrophils reduced LH-stimulated luteal 88 
progesterone synthesis.  In contrast, activated polymorphic mononuclear cells (PBMCs) 89 
inhibited LH-stimulated progesterone by luteal cells in vitro. The activation of immune cells 90 
during luteolysis may be involved in the regression of the bovine corpus luteum. 91 
 92 
Materials and Methods 93 
In vivo Studies 94 
All animal procedures were conducted under an IACUC-approved protocol and performed at the 95 
University of Nebraska-Lincoln, Animal Sciences Department. Post-pubertal female cattle of 96 
composite breeding age were given an intramuscular injection at midcycle (days 9-10) with 97 
saline (n = 3) or 25 mg of the PGF analogue, Lutalyse (Pharmacia & Upjohn Company, New 98 
York, NY, n = 12).  Ovariectomies were performed at 0.5, 1, 2, and 4 h after PGF treatment and 99 
RNA was isolated from the corpora lutea using an Absolutely mRNA Purification Kit (Agilent 100 
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Technologies Inc., Santa Clara, CA.) according to the manufacturer’s instructions.  RNA yields 101 
were measured using a fluorescence detection kit (RiboGreen; Invitrogen, Carlsbad, CA).  102 
Screening with whole-transcript bovine microarray (Affymetrix, Santa Clara, CA) revealed 103 
several chemokines that were induced following treatment with PGF.  Quantitative real-time 104 
PCR (qPCR) was used to validate changes in IL8, CCL2, CCL8, and CXCL2 mRNA using the 105 
primers provided in Table 1.  First-strand cDNA was synthesized from 1 µg total RNA using 106 
iScriptTM cDNA synthesis kit (Bio-Rad, Hercules, CA) according to the manufacturers' 107 
instructions.  qPCR was performed using the CFX96TM Real-Time PCR Detection System (Bio-108 
Rad, Hercules, CA) with ssoFastTM EvaGreen® Supermix (Bio-Rad, Hercules, CA) with the 109 
following parameters: 95 °C for 30 s followed by 40 cycles of: 95 °C for 5 s, and 55 °C for 5 s.  110 
ACTB or GADPH were used as internal standards of mRNA expression.  The authenticity of the 111 
PCR signal was verified by reactions containing no RNA or reactions omitting reverse 112 
transcriptase.  Melt curve analysis was performed to ensure amplification of a single product at 113 
the predicted melting temperature. 114 
 115 
In vitro Studies 116 
All cell culture experiments described below were done in tissue culture plastic (Corning CoStar, 117 
Corning, NY) and included penicillin (100 IU/ml, Gibco Life Technologies, Carlesbad, CA) 118 
streptomycin (100 µg/ml, Gibco Life Technologies, Carlesbad, CA), and amphotericin (50 µg/ml, 119 
MP Biomedicals, Santa Ana, CA) in cell culture medium to prevent bacterial and fungal growth. 120 
 121 
Isolation of Bovine Luteal cells 122 
Bovine ovaries were collected from a local abattoir (XL Four Star Beef, Omaha, NE).  The tissue 123 
was obtained from cows during early pregnancy (fetal crown rump length < 10 cm) to assure 124 
luteal function (Ireland et al. 1980).  The luteal tissue was dissected from the ovary and 125 
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dissociated with 103 IU/mL collagenase (Atlanta Biologicals, Norcross, GA) as described 126 
previously (Chakravorty et al. 2013).  Luteal cell viability was determined using trypan blue 127 
exclusion, and luteal cell preparations with more than 90% viability were used.  Enriched bovine 128 
steroidogenic luteal cells (1 × 105 cells/cm2) were plated as previously described (Hou et al. 129 
2010).  Cells were incubated overnight in medium 199 (M199, Lonza, Basel, Switzerland) 130 
supplemented with 5% fetal bovine serum (FBS, Valley Biomedical, Winchester, VA).  The next 131 
day the medium was changed and the incubations were continued for 1 day in FBS-free media.  132 
On the day of the experiment, the medium was replaced with fresh FBS-free medium for 2-3 h 133 
to pre-equilibrate before applying the treatments detailed in the figure legends.  134 
 135 
Isolation of Bovine Endothelial and Fibroblast cells 136 
Endothelial cells were isolated from bovine corpus luteum of early pregnancy and purified as 137 
described before (Maroni & Davis 2011).  Endothelial cells were positive for vascular endothelial 138 
cell cadherin (VE-cadherin) and negative for steroidogenic enzymes and prolyl 4-hydroxylase 139 
(antibodies are listed in Table 2).  Cells were grown to ~80% confluence in Dulbecco’s Modified 140 
Eagle Medium (DMEM, Corning CellGro, Corning, NY) containing 10% FBS and 20 µg/ml 141 
endothelial cell growth supplement (ECGS, Millipore, Bedford, MA).  The medium was changed 142 
to serum-free DMEM containing 20 µg/ml ECGS for 2 h prior to the treatments described in the 143 
figure legends.   144 
 145 
Fibroblasts were isolated from the bovine corpus luteum and characterized as previously 146 
described (Maroni & Davis 2012).  The fibroblasts were positive for prolyl 4-hydroxylase and 147 
collagen 1 and negative for steroidogenic enzymes and VE-cadherin (antibodies listed in Table 148 
2).  Luteal fibroblasts were grown to ~80% confluence and changed to serum-free DMEM for 2 149 
h prior to treatment with IL8 as described in the figure legends.   150 
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 151 
Isolation of bovine neutrophils and migration assays 152 
Potassium EDTA (Sigma-Aldrich, St. Louis, MO)-anticoagulated bovine blood samples were 153 
collected from a local abattoir (XL Four Star Beef, Omaha, NE), centrifuged, and subjected to 154 
Percoll gradient (Sigma-Aldrich, St. Louis, MO) separation to isolate neutrophils.  The remaining 155 
erythrocytes were lysed by rapid treatment with dH2O and the remaining cells were 156 
resuspended in Roswell Park Memorial Institute 1640 medium (RPMI, Thermo Fisher Scientific 157 
HyClone, Waltham, MA).  Cell migration was assayed using the Boyden chamber method.  158 
Bovine neutrophils (2.5 x 105) were seeded in transparent PET membrane cell culture inserts 159 
with 3 µm pores (B&D Falcon, Franklin Lakes, NJ) placed in 24-well plates.  The lower chamber 160 
was filled with 500 µl RPMI with or without 30 ng/mL IL8 (R&D Systems, Minneapolis, MN), 100 161 
nM PGF2α, 10 ng/ml tumor necrosis factor alpha (TNF, R&D Systems, Minneapolis, MN) or 1 162 
ng/ml transforming growth factor beta 1 (TGFB1).  Cell migration was carried out for up to 24 h 163 
at 37 °C.  Migrated cells were counted with a hemacytometer. 164 
 165 
To determine the signaling pathways used by IL8 in bovine neutrophils, we treated neutrophils 166 
with IL8 or TNF (R&D Systems, Minneapolis, MN), a modulator of immune function and 167 
activator of multiple signaling pathways.  Western blot analysis was performed to examine the 168 
mitogen-activated protein kinase (ERK1/2, p38 and JNK), AKT and NFκB signaling pathways 169 
using phospho-specific antibodies.  See Table 2 for a complete list of antibodies used. 170 
 171 
Isolation of human neutrophils and degranulation assays 172 
Human neutrophils were isolated from peripheral blood of healthy donors by density gradient 173 
centrifugation under an approved IRB at the University of Nebraska Medical Center, using 174 
polymorphprep (Axis-Shield, Oslo, Norway) in accordance with manufacturer’s instruction.  175 
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Purified neutrophils were re-suspended in RPMI + 5% FBS.  Neutrophils (3 x 105 cells) were 176 
incubated with different concentrations of IL8 at 37 °C for 1 h.  Neutrophil degranulation was 177 
examined by florescence-activated cell sorting for increased cell surface expression of granule 178 
molecules carcinoembryonic antigen-related cell adhesion molecule 8 (CD66b); and integrin 179 
alpha M (CD11b).  Cells were stained with fluorescein isothiocynate (FITC)-conjugated mouse 180 
anti-human CD66b antibody and allophycocyanin (APC)-conjugated mouse anti-human CD11b 181 
antibody on ice for 30 min.  After rinsing, cells were fixed with PBS plus 2% formaldehyde.  Flow 182 
cytometry analysis was done using a Becton Dickinson (Franklin Lakes, NJ) FACSCaliber flow 183 
cytometer and was performed at the UNMC Cell and Tissue Analysis Facility. 184 
 185 
Isolation of bovine peripheral blood mononuclear cells 186 
Acid citrate dextrose-anticoagulated blood samples from cows were collected from a local 187 
abattoir (XL Four Star Beef, Omaha, NE).  Blood was then diluted 1:2 in cold Hank’s Balance 188 
Salt Solution (HBSS, Corning CellGro, Corning, NY) with 2 mM EDTA (Sigma-Aldrich, St. Louis, 189 
MO) and 5% FBS.  Diluted blood was underlayed with an equal volume of Histopaque (specific 190 
gravity = 1.083, Sigma-Aldrich, St. Louis, MO) and centrifuged at 900 x g for 30 min.  PBMCs 191 
were collected from interface between the plasma and Histopaque.  The cells were then washed 192 
in HBSS three times before use. 193 
 194 
Co-culture experiments 195 
Enriched bovine steroidogenic luteal cells were plated (∼1 × 105 cells/cm2) in basal M199 196 
medium containing 5% FBS in 48-well plates overnight as described above.   197 
 198 
Neutrophil-luteal cell co-culture:  199 
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Neutrophils were isolated on the same day that luteal cells were prepared.  Purified neutrophils 200 
were then cultured in RPMI (10% FBS) with or without 30 ng/ml IL8 and 20 nM phorbol 201 
myristate acetate (PMA, EMD Millipore Calbiochem, Billerica, MA) overnight.  After 24 h the 202 
medium was replaced on the luteal cell cultures.  Neutrophils (250,000 cells/ml) were then 203 
added to the luteal cells in M199 and RPMI (1:1) with 10% FBS for 2 h before adding control 204 
media or 10 ng/ml bLH (Tucker Endocrine Research Institute, Atlanta, GA).  Medium from each 205 
well was collected 6 hours after LH or control treatments for progesterone analysis. 206 
 207 
PBMC-luteal cell co-culture: 208 
Twenty-four hours after plating the luteal cells, the medium was removed from the culture wells 209 
and replaced with fresh M199.  Then an equal volume of newly isolated bovine PBMCs in RPMI 210 
(100,000 cells/ml) were added to the luteal cell culture.  Co-cultures were incubated for 24 h in 211 
M199 and RPMI (1:1 ratio) + 10% FBS, and with or without 10 µg/ml concavalin A (Sigma, St. 212 
Louis, MO) to activate the PBMCs.  After 24 h of co-culture, medium was replaced with 213 
M199:RPMI + 10% FBS for 2 h to pre-equilibrate the cells before the addition of control media 214 
or 10 ng/ml LH.  Medium was removed from each well after 6 h of control or LH treatment for 215 
progesterone analysis. 216 
 217 
Western blot analysis 218 
Cultures of neutrophils, steroidogenic cells, luteal endothelial cells, and luteal fibroblasts were 219 
harvested with ice cold cell lysis buffer [20 mM Tris-HCl (pH = 7), 150 mM NaCl, 1 mM 220 
Na2EDTA, 1 mM EGTA, 1% Triton X-100 and protease and phosphatase inhibitor cocktails 221 
(Sigma-Aldrich, St. Louis, MO)].  Protein concentration was determined and 40-60 µg protein 222 
was subjected to 10% SDS-PAGE.  After transfer to polyvinylidene fluoride (PVDF) membranes, 223 
the membranes were probed with appropriate amounts of primary antibodies and bound 224 
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antibodies were detected with a horse radish peroxidase (HRP) conjugated secondary antibody 225 
and the Femto Western Blotting Detection Kit (GE Healthcare Amersham, Cleveland, OH).  226 
Signals were visualized using a Digital Sciences Image Station 440 (Kodak, Rochester, NY). 227 
 228 
Progesterone Analysis 229 
Conditioned media were collected for progesterone determination using Coat-A-Count 230 
progesterone RIA kit (Siemens, Deerfield, IL) according to the manufacturer’s instructions and 231 
as previously reported (Hou et al. 2010). 232 
 233 
Statistical Analysis 234 
All experiments were performed at least two times using different cell preparations with 235 
qualitatively comparable results.  The data are presented as representative experiments or as 236 
the means ± SEM of the averages from multiple experiments.  The differences in means were 237 
analyzed by t test or ANOVA followed by multiple range testing.  P < 0.05 was considered 238 
statistically significant. 239 
 240 
Results 241 
PGF Stimulates Chemokine Gene Expression In Vivo 242 
Treatment with PGF in vivo resulted in a 4.3 ± 1.0-fold increase in IL8 mRNA within 30 min and 243 
a 8.9 ± 2.2-fold increase in IL8 mRNA within 1 h of administration (Figure 1A).  Treatment with 244 
PGF also increased CCL8, CXCL2, and CCL2 mRNA after 1 h (fold increases of 2.5 ± 0.6; 2.9 ± 245 
0.7 and 3.1 ± 0.6, respectively). After a brief lag the expression of chemokine mRNA increased 246 
dramatically after 4 h of treatment with PGF.  A 35 ± 4 fold increase in IL8 mRNA expression 247 
was observed in response to a 4 h treatment with PGF.  At the 4 h mark PGF also stimulated 248 
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significant (P < 0.05) increases in CCL8, CCL2 and CXCL2 mRNA expression (29 ± 3.8, 12 ± 249 
1.5 and 6.4 ± 1 fold, respectively).   250 
 251 
PGF Stimulates IL8 Expression In Vitro 252 
Treatment of steroidogenic luteal cells with PGF for 1 h in vitro also increased IL8 mRNA 253 
expression (2.7 ± 0.3-fold increase, P < 0.05; Figure 1B).  Luteal steroidogenic cells were 254 
pretreated in the presence or absence of specific inhibitors of the mitogen-activated protein 255 
kinase (MAPK) signaling cascade to determine which intracellular signals contribute to the 256 
stimulatory effect of PGF on the induction of IL8 gene expression (Figure 1B).  Pretreatment 257 
with the ERK1/2 inhibitor U0126 (Enzo Life Sciences, Farmingdale, NY) failed to prevent the 258 
stimulatory effect of PGF on IL8 mRNA (Figure 1B).  In contrast, inhibition of the stress-259 
activated protein kinase p38 MAPK with SB2037580 resulted in a complete inhibition of the 260 
response to PGF. Treatment with the JNK inhibitor SP600125 also resulted in a significant 261 
inhibition (77%, P < 0.05) of the PGF-induced increase in IL8 mRNA.  262 
 263 
IL8 Induces Migration of Bovine Neutrophils 264 
To determine whether IL8 would affect the function of bovine neutrophils, we purified neutrophils 265 
from blood collected at slaughter from cows.  As shown in Figure 2A neutrophils stained with 266 
hematoxylin and eosin had distinct multi-lobular nuclei, a characteristic of neutrophils.  A 267 
Boyden chamber assay (Figure 2A) was used to determine whether IL8 or other factors 268 
produced during luteolysis could increase migration of bovine neutrophils.  We observed that 269 
treatment for 18 h with 30 ng/ml IL8 caused a 20-fold (P < 0.05) increase in neutrophil 270 
migration.  However, treatment of neutrophils with 100 nM PGF under identical conditions had 271 
no effect on neutrophil migration (Figure 2B).  Migration assays were also performed with other 272 
chemokines that have been implicated in luteal regression; namely TNF (Henkes et al. 2008,  273 
Page 11 of 40
 Page 12 of 32 
 
Skarzynski et al. 2009) and TGFB1 (Maroni & Davis 2011, 2012) .  In experiments evaluating 274 
neutrophil migration during a 3 h treatment period, we found that 30 ng/ml IL8, but not 100 nM 275 
PGF, 10 ng/ml TNF, or 1 ng/ml TGFB1, was capable of stimulating migration of neutrophils 276 
(Figure 2C). 277 
 278 
Activation of neutrophils results in the rapid cell surface expression of molecules that allows for 279 
endothelium attachment for extravasation.  Treatment of human neutrophils with increasing 280 
concentrations of human IL8 (0-100 ng/ml) resulted in the rapid expression of the cell adhesion 281 
molecules CDIIb (integrin alpha-M0, ITGAM) and CD66b (carcinoembryonic antigen-related cell 282 
adhesion molecule 8, CEACAM8) as determined by flow cytometry (not shown). 283 
 284 
IL8 selectively stimulates signaling in bovine neutrophils 285 
Treatment with IL8 for 15 min stimulated an increase (5-fold, P < 0.05) in ERK1/2 286 
phosphorylation (Figure 3A).  The response was transient and returned to control levels within 287 
120 min following IL8 treatment (Figures 3A and 5A).  IL8 did not stimulate either the p38 or the 288 
JNK MAPK signaling pathways (Figure 3A).  TNF was used as a positive control since it 289 
activates many signaling pathways in immune cells.  In contrast to IL8, TNF provoked sustained 290 
ERK phosphorylation, as well as p38 and JNK phosphorylation in bovine neutrophils throughout 291 
the 120 min investigated (Figure 3A).  IL8 exerted a slight, but consistent, increase in the 292 
phosphorylation of p65-NFκB and AKT; whereas, TNF stimulated a robust increase in p65 NFkB 293 
and AKT phosphorylation in neutrophils.  To determine whether IL8 could similarly stimulate 294 
other cells of the corpus luteum, we treated bovine luteal fibroblasts, endothelial cells and 295 
steroidogenic cells with IL8 under various treatment times and concentrations.  IL8 did not 296 
stimulate the phosphorylation of AKT, ERK or NFκB in any of these luteal cell types. As a 297 
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positive control we observed that TNF stimulated MAPK and NFκB signaling in each cell type 298 
examined (data not shown).  299 
 300 
In view of the very prominent effect of IL8 on ERK signaling in neutrophils, we tested whether 301 
the IL8-induced increase in ERK phosphorylation was associated with the effect of IL8 on 302 
neutrophil migration.  Pretreatment with 5 µM of U0126, completely blocked the induction of 303 
ERK phosphorylation (Figure 4A), but did not prevent the stimulatory effect of IL8 on bovine 304 
neutrophil migration (Figure 4B).  305 
 306 
Effect of IL8 and immune cells on progesterone secretion 307 
Experiments were performed to determine whether IL8 altered progesterone secretion.  308 
Pretreatment of steroidogenic luteal cells with increasing amounts of IL8 (0-30 ng/ml) did not 309 
alter basal or LH-simulated progesterone production in luteal cells (Figure 5A).  Next, we co-310 
cultured neutrophils with steroidogenic cells and evaluated the ability of LH to stimulate 311 
progesterone secretion.  We observed that co-cultures of steroidogenic cells and neutrophils 312 
had no effect on the ability of LH to increase progesterone (Figure 5B).  Furthermore, co-313 
cultures of steroidogenic cells and activated neutrophils had no effect on basal or LH-stimulated 314 
progesterone production.   315 
 316 
Co-cultures of steroidogenic cells and PBMCs had no effect on the ability of LH to secrete 317 
progesterone (Figure 6).  However, LH-stimulated progesterone production was completely 318 
abrogated (P < 0.05) in cultures of activated PBMCs and steroidogenic luteal cells (Figure 6). 319 
320 
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Discussion  321 
 322 
For over thirty years the immune system has been postulated as essential for fertility (Espey 323 
1980).  The present study provides additional insight into the expression and function of 324 
chemokines during luteal regression.  We observed that induction of luteal regression in cows 325 
with a bolus of PGF in vivo resulted in a rapid increase in the expression of IL8, CCL8, CCL2, 326 
and CXCL2. Our findings confirm recent findings by (Shirasuna et al. 2012a) that PGF treatment 327 
of dairy cattle increased luteal IL8 mRNA by approximately 4-fold within 30  min.  In that study, 328 
the fold increase in IL8 mRNA remained constant over a 12 h of period of treatment with PGF. 329 
In the present study using beef cattle we observed more robust increases in luteal IL8 mRNA 330 
expression; 9-fold increases within 1 h and 35-fold increases after 4 h of PGF treatment.  At 331 
present it is not clear whether the differences in the magnitude of the responses are due to 332 
differences in the cattle breeds or other factors, because there are reported differences in the 333 
responses of beef and dairy cattle to synchronization protocols using PGF (Lucy et al. 2001).  334 
Based on the pronounced increase in IL8 expression, it was selected for further analysis.  We 335 
found that IL8 acted directly on neutrophils but had little effect on other cell types in the mid-336 
cycle corpus luteum. Furthermore, co-cultures of luteal cells with activated neutrophils did not 337 
alter LH-stimulated progesterone synthesis; whereas co-cultures with activated PBMCs 338 
suppressed LH-stimulated progesterone synthesis. 339 
  340 
Activation of the PGF receptor rapidly induces calcium mobilization and activation of PKC 341 
(Davis et al. 1987). These initial signaling events lead to the activation of ERK1/2 (Chen et al. 342 
1998,  Arvisais et al. 2010), p38, and JNK (Yadav et al. 2002,  Yadav & Medhamurthy 2006,  343 
Mao et al. 2013) in vivo and in vitro, with subsequent activation of multiple transcription factors.  344 
The MAPK signaling family induces early-response genes such as FOS and JUN (Chen et al. 345 
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2001), NR4A1 (Stocco et al. 2007,  Atli et al. 2012), EGR1 (Hou et al. 2008,  Atli et al. 2012), 346 
and ATF3 (Mondal et al. 2011,  Mao et al. 2013) in the corpus luteum.  To determine which 347 
intracellular signals contribute to the stimulatory effect of PGF on IL8 gene expression, luteal 348 
cells were treated with specific inhibitors of ERK1/2, p38, and JNK.  We observed that the 349 
ERK1/2 inhibitor U0126 had no effect on IL8 mRNA expression in response to PGF, while the 350 
p38 MAPK inhibitor SB2037580 and the JNK inhibitor SP600125 significantly inhibited the PGF-351 
mediated upregulation of IL8 mRNA.  The results indicate that the stress-activated MAPKs: p38 352 
and JNK play an important and perhaps overlapping role in the induction of IL8 mRNA in 353 
response to PGF. 354 
 355 
Chemokines like IL8 are responsible for the recruitment of immune cells to chemokine-356 
producing tissues.  Our findings demonstrate that IL8 is chemotactic for bovine neutrophils, in 357 
agreement with previous literature (Mukaida 2000, 2003,  Jiemtaweeboon et al. 2011,  358 
Shirasuna et al. 2012a) .  IL8 stimulated a 6-fold increase in neutrophil migration within 3 h and 359 
after 24 h IL8-treatment increased neutrophil migration nearly 20-fold.  In contrast, treatment 360 
with PGF had no effect on neutrophil migration at either time point. These findings are 361 
consistent with the studies by (Liptak et al. 2005,  Shirasuna et al. 2012a) showing that immune 362 
cells are unresponsive to PGF because they do not express the PGF receptor.  In the present 363 
study we also report that TNF and TGBF1, two cytokines induced rapidly in the bovine corpus 364 
luteum in response to PGF and implicated in events associated with luteal regression (Henkes 365 
et al. 2008,  Hou et al. 2008,  Mondal et al. 2011,  Maroni & Davis 2012) did not increase the 366 
migration of bovine neutrophils in the Boyden chamber assay.  Our observations support the 367 
recent reports (Sales et al. 2009,  Mondal et al. 2011,  Atli et al. 2012,  Shirasuna et al. 2012a)  368 
showing that PGF induces IL8 mRNA and that the expression of IL8 is associated with the 369 
appearance of neutrophils in the bovine corpus luteum (Jiemtaweeboon et al. 2011,  Shirasuna 370 
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et al. 2012a, 2012b) .  In addition, our studies indicate that IL8 stimulates the degranulation of 371 
human neutrophils which may be important for their migration from the blood into the corpus 372 
luteum.  These findings correspond with the studies of Shirasuna et al. (2012a) demonstrating 373 
the rapid appearance of P-selectin on endothelial cells following treatment with PGF, which 374 
allows for adhesion of neutrophils to endothelial cells.  Other chemokines (CCL8, CCL2, and 375 
CXCL2) are induced concomitantly with IL8, therefore it will be important to evaluate the 376 
contributions of each individual chemokine to the recruitment of specific immune cells into the 377 
regressing corpus luteum. Future experiments should also address how combinations of these 378 
chemokines signal the recruitment and activation of immune cells within the corpus luteum 379 
(Gouwy et al. 2008).  380 
 381 
 Treatment of neutrophils with IL8 stimulated a robust increase in ERK phosphorylation, a slight 382 
increase in AKT and NFκB phosphorylation, and had no effect on p38 and JNK signaling.  In 383 
contrast, TNF activated all of these pathways simultaneously in neutrophils.  Since ERK 384 
signaling was the most prominent pathway activated following IL8 treatment of bovine 385 
neutrophils, we determined whether neutrophil migration could be blocked by treatment with the 386 
MEK1/2 inhibitor U0126.  Interestingly, we found that inhibition of ERK signaling with U0126 had 387 
no inhibitory effect on IL8-stimulated neutrophil migration. These results suggest that another 388 
signaling pathway is responsible for IL8-stimulated chemotaxis, likely the PI3K and RAC 389 
signaling pathway (Neptune et al. 1999,  Futosi et al. 2013) .  Further studies are required to 390 
determine the contributions of other signaling pathways to neutrophil activation and migration. 391 
 392 
IL8 has been shown to induce diverse cellular responses in cells other than neutrophils 393 
(Mukaida 2003) . Recent studies suggest that IL8 may contribute to angiogenesis in the newly 394 
forming corpus luteum (Jiemtaweeboon et al. 2011) and progesterone secretion by granulosa 395 
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(Shimizu et al. 2012) and theca (Shimizu et al. 2013) cells. Treatment with various IL8 396 
concentrations and treatment times revealed no changes in cell signaling in steroidogenic cells, 397 
endothelial cells, or fibroblasts isolated from the bovine corpus luteum. However, IL8 stimulated 398 
a robust increase in ERK phosphorylation in neutrophils. Furthermore, IL8 did not affect basal or 399 
LH-stimulated progesterone secretion from cultured luteal cells.  In contrast to the findings by 400 
Shimizu et al. 2012 using cells from the ovarian follicle, we found no evidence suggesting that 401 
IL8 acted directly on bovine luteal cells types that are involved in luteal regression (e.g., 402 
endothelial cells, fibroblasts and steroidogenic cells).  Based on these findings it appears that 403 
IL8 exerts specific effects on ovarian cell types depending on their stage of differentiation. Given 404 
that the corpus luteum is highly differentiated and undergoes regression in response to PGF, 405 
the lack of a stimulatory effect of IL8 on angiogenesis and steroidogenesis may be expected 406 
since the vasculature and steroid secretion are disrupted during regression (Davis & Rueda 407 
2002,  Niswender 2002,  Stocco et al. 2007,  Maroni & Davis 2012).  It is possible that during 408 
luteal regression IL8-activated neutrophils contribute to phagocytosis during structural 409 
regression of the corpus luteum. 410 
 411 
The increase observed in multiple chemokines suggests that immune cells other than 412 
neutrophils could be recruited in to the corpus luteum following administration of PGF.  In fact, 413 
studies from multiple laboratories have demonstrated an increase in neutrophils, T cells, or 414 
macrophages during the regression of the corpus luteum in rodents (Kuranaga et al. 1999), 415 
rabbits (Krusche et al. 2002), ruminants (Murdoch 1987,  Penny et al. 1999), primates 416 
(Braundmeier et al. 2012) and women (Wang et al. 1992,  Best et al. 1996,  Gaytan et al. 1998,  417 
Suzuki et al. 1998). A previous report indicated that co-culture of rat neutrophils with luteal cells 418 
resulted in a decrease in progesterone secretion, presumably as a result of oxidative stress 419 
(Behrman et al. 2001).  However, under our experimental conditions co-cultures of bovine 420 
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neutrophils and steroidogenic luteal cells did not alter basal or LH-stimulated progesterone 421 
synthesis.  Treatment of neutrophils with IL8 and PMA, alone or in combination, to activate 422 
neutrophils was not sufficient to reduce progesterone secretion under co-culture conditions. In 423 
addition to neutrophils, monocytes are immune effector cells that are also equipped with 424 
chemokine receptors and adhesion receptors that mediate migration from blood to tissues 425 
(Murray & Wynn 2011).  Since we observed that PGF rapidly induced the expression of other 426 
chemokines (CCL8, CCL2, and CXCL2), which could recruit other types of immune cells, we 427 
established a co-culture system with PBMCs and luteal cells. Although, un-activated PBMCs did 428 
not reduce progesterone secretion, we observed that activated PBMCs effectively reduced LH-429 
driven progesterone secretion.  These observations support our earlier findings (Liptak et al. 430 
2005) that activated immune cells may contribute a factor (or factors) that impair 431 
steroidogenesis in response to LH. It is known that activated monocytes produce inflammatory 432 
cytokines, nitric oxide, and reactive oxygen species (Murray & Wynn 2011,  Zhou et al. 2014) all 433 
of which may contribute individually or in combination to the inhibition of progesterone synthesis 434 
(Al-Gubory et al. 2012,  Quirk et al. 2013,  Skarzynski et al. 2013).  In the in vivo setting, 435 
activated monocytes may also secrete matrix metalloproteinases that contribute to the 436 
degradation of the extracellular matrix (Murray & Wynn 2011), which could facilitate the 437 
recruitment of additional inflammatory cells to the regressing corpus luteum. 438 
 439 
A complex interaction of endocrine and immune cells appears to be required to mediate the 440 
structural and functional regression of the bovine corpus luteum.  Since chemokines act 441 
synergistically to activate their target cells (Gouwy et al. 2008), additional studies are needed to 442 
examine the actions of chemokines as a complex cocktail rather than in isolation, as performed 443 
in the present study. The current findings complement a recent review (Walusimbi & Pate 2013) 444 
that postulates that immune cells in the developing and functional corpus luteum play a 445 
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supportive role, but once corpus luteum regression is triggered, the immune cells promote 446 
apoptosis, debris clearage and tissue remodeling.  Understanding these endocrine and immune 447 
events is important for increasing our ability to control reproductive function to facilitate full-term 448 
pregnancies in both humans and livestock. 449 
 450 
Declaration of interest 451 
The authors have no declarations of interest to disclose. 452 
 453 
Funding 454 
This project was supported by Agriculture and Food Research Initiative Competitive Grant no.  455 
2011-67015-20076 from the USDA National Institute of Food and Agriculture (JSD); the 456 
Department of Veterans Affairs (JSD), the National Institutes of Health 1 P01 AG029531; the 457 
Olson Center for Women’s Health (AD and JSD), and an Exceptional Incoming Graduate 458 




Page 19 of 40
 Page 20 of 32 
 
References 463 
Al-Gubory KH, Garrel C, Faure P & Sugino N 2012 Roles of antioxidant enzymes in corpus 464 
luteum rescue from reactive oxygen species-induced oxidative stress. Reproductive 465 
Biomedicine Online 25 551–60. 466 
Arvisais E, Hou X, Wyatt TA, Shirasuna K, Bollwein H, Miyamoto A, Hansen TR, Rueda 467 
BR & Davis JS 2010 Prostaglandin F2α represses IGFI-stimulated IRS1/Phosphatidylinositol-3-468 
Kinase/AKT signaling in the corpus luteum: role of ERK and P70 ribosomal S6 kinase. 469 
Molecular Endocrinology 24 632–643. 470 
Atli MO, Bender RW, Mehta V, Bastos MR, Luo W, Vezina CM & Wiltbank MC 2012 Patterns 471 
of gene expression in the bovine corpus luteum following repeated intrauterine infusions of low 472 
doses of prostaglandin F2alpha. Biology of Reproduction 86 1–13. 473 
Behrman HR, Kodaman PH, Preston SL & Gao S 2001 Oxidative stress and the ovary. 474 
Journal of the Society for Gynecologic Investigation 8 40–43. 475 
Best CL, Pudney J, Welch WR, Burger N & Hill JA 1996 Localization and characterization of 476 
white blood cell populations within the human ovary throughout the menstrual cycle and 477 
menopause. Human Reproduction 11 790–797. 478 
Bogan RL, Murphy MJ, Stouffer RL & Hennebold JD 2008 Prostaglandin synthesis, 479 
metabolism, and signaling potential in the rhesus macaque corpus luteum throughout the luteal 480 
phase of the menstrual cycle. Endocrinology 149 5861–5871. 481 
Page 20 of 40
 Page 21 of 32 
 
Braundmeier A, Jackson K, Hastings J, Koehler J, Nowak R & Fazleabas A 2012 Induction 482 
of endometriosis alters the peripheral and endometrial regulatory T cell population in the non-483 
human primate. Human Reproduction 27 1712–1722. 484 
Care AS, Diener KR, Jasper MJ, Brown HM, Ingman W V & Robertson, Sarah A 2013 485 
Macrophages regulate corpus luteum development during embryo implantation in mice. The 486 
Journal of Clinical Investigation 123 3472–3487. 487 
Chakravorty A, Joslyn MI & Davis JS 1993 Characterization of insulin and insulin-like growth 488 
factor-I actions in the bovine luteal cell: regulation of receptor tyrosine kinase activity, 489 
phosphatidylinositol-3-kinase, and deoxyribonucleic acid synthesis. Endocrinology 133 1331–490 
1340. 491 
Chen D, Fong HW & Davis JS 2001 Induction of c-fos and c-jun messenger ribonucleic acid 492 
expression by prostaglandin F2alpha is mediated by a protein kinase C-dependent extracellular 493 
signal-regulated kinase mitogen-activated protein kinase pathway in bovine luteal cells. 494 
Endocrinology 142 887–895. 495 
Chen D, Westfall SD, Fong HONW, Roberson MS & Davis JS 1998 Prostaglandin F2 496 
stimulates the Raf/MEK1/Mitogen-Activated Protein Kinase signaling cascade in bovine luteal 497 
cells. Endocrinology 139 3876–3885. 498 
Davis JS & Rueda BR 2002 The corpus luteum: an ovarian structure with maternal instincts 499 
and suicidal tendencies. Frontiers in Bioscience 7 1949–1978. 500 
Davis JS, Weakland LL, Weiland DA, Farese RV & West LA 1987 Prostaglandin F2a 501 
stimulates phosphatidylinositol 4,5-bisphosphate hydrolysis and mobilizes intracellular Ca2" in 502 
bovine luteal cells. Proceedings of the National Academy of Sciences 84 3728–3732. 503 
Page 21 of 40
 Page 22 of 32 
 
Erlebacher A, Zhang D, Parlow AF & Glimcher LH 2004 Ovarian insufficiency and early 504 
pregnancy loss induced by activation of the innate immune system. The Journal of Clinical 505 
Investigation 114 39–48. 506 
Espey LL 1980 Ovulation as an inflammatory reaction - a hypothesis. Biology of Reproduction 507 
22 73–106. 508 
Futosi K, Fodor S & Mócsai A 2013 Neutrophil cell surface receptors and their intracellular 509 
signal transduction pathways. International Immunopharmacology 17 1185–1197. 510 
Gaytan F, Morales C, Garcia-Pardo L, Reymundo C, Bellido C & Sanchez-Criado JE 1998 511 
Macrophages, cell proliferation, and cell death in the human menstrual corpus luteum. Biology 512 
of Reproduction 59 417–425. 513 
Gouwy M, Struyf S, Noppen S, Schutyser E, Springael JY, Parmentier M, Proost P & Van 514 
Damme J 2008 Synergy between coproduced CC and CXC chemokines in monocyte 515 
chemotaxis through receptor-mediated events. Molecular Pharmacology 74 485–495. 516 
Heidemann J, Ogawa H, Dwinell MB, Rafiee P, Maaser C, Gockel HR, Otterson MF, Ota 517 
DM, Lugering N, Domschke W & Binion DG 2003 Angiogenic effects of interleukin 8 (CXCL8) 518 
in human intestinal microvascular endothelial cells are mediated by CXCR2. The Journal of 519 
Biological Chemistry 278 8508–8515. 520 
Henkes LE, Sullivan BT, Lynch MP, Kolesnick R, Arsenault D, Puder M, Davis JS & Rueda 521 
BR 2008 Acid sphingomyelinase involvement in tumor necrosis factor a-regulated vascular and 522 
steroid disruption during luteolysis in vivo. Proceedings of the National Academy of Sciences 523 
105 7670–7675. 524 
Page 22 of 40
 Page 23 of 32 
 
Hou X, Arvisais E & Davis J 2010 Luteinizing hormone stimulates mammalian target of 525 
rapamycin signaling in bovine luteal cells via pathways independent of AKT and mitogen-526 
activated protein kinase. Endocrinology 151 2846–2857. 527 
Hou X, Arvisais E, Jiang C, Chen D,  Roy SK, Pate JL, Hansen TR, Rueda BR & Davis JS  528 
2008 Prostaglandin F2α stimulates the expression and secretion of transforming growth factor 529 
B1 via induction of the early growth response 1 gene (EGR1) in the bovine corpus luteum. 530 
Molecular Endocrinology 22 403–414. 531 
Ireland JJ, Murphee RL & Coulson PB 1980 Accuracy of predicting stages of bovine estrous 532 
cycle by gross appearance of the corpus luteum. Journal of Dairy Science 63 155–160. 533 
Jiemtaweeboon S, Shirasuna K, Nitta A, Kobayashi A, Schuberth H, Shimizu T & 534 
Miyamoto A 2011 Evidence that polymorphonuclear neutrophils infiltrate into the developing 535 
corpus luteum and promote angiogenesis with interleukin-8 in the cow. Reproductive Biology 536 
and Endocrinology 9 79. 537 
Kawaguchi S, Bowolaksono A, Yoshioka S, Sakumoto R & Okuda K 2013 Luteoprotective 538 
mechanisms of prostaglandin F2α stimulated by luteinizing hormone in the bovine corpus 539 
luteum. The Journal of Reproduction and Development 59 2–7. 540 
Krusche CA, Vloet TD, Herrler A, Black S & Beier HM 2002 Functional and structural 541 
regression of the rabbit corpus luteum is associated with altered luteal immune cell phenotypes 542 
and cytokine expression patterns. Histochemistry and Cell Biology 118 479–489. 543 
Kuranaga E, Kanuka H, Bannai M, Suzuki M, Nishihara M & Takahashi M 1999 Fas/Fas 544 
ligand system in prolactin-induced apoptosis in rat corpus luteum: possible role of luteal immune 545 
cells. Biochemical and Biophysical Research Communications 260 167–173. 546 
Page 23 of 40
 Page 24 of 32 
 
Li A, Dubey S, Varney ML, Dave BJ & Singh RK 2003 IL-8 directly enhanced endothelial cell 547 
survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. 548 
Journal of Immunology 170 3369–3376. 549 
Liptak AR, Sullivan BT, Henkes LE, Wijayagunawardane MPB, Miyamoto A, Davis JS, 550 
Rueda BR & Townson DH 2005 Cooperative expression of monocyte chemoattractant protein 551 
1 within the bovine corpus luteum: evidence of immune cell-endothelial cell interactions in a 552 
coculture system. Biology of Reproduction 72 1169–1176. 553 
Lucy M, Billings H, Butler WR, Ehnis LR, Fields MJ, Kesler DJ, Kinder JE, Mattos RC, 554 
Short RE, Thatcher WW, Wettemann RP, et al. 2001 Efficacy of an intravaginal progesterone 555 
insert and an injection of PGF2alpha for synchronizing estrus and shortening the interval to 556 
pregnancy in postpartum beef cows, peripubertal beef heifers, and dairy heifers. Journal of 557 
Animal Science 79 982–995. 558 
Mao D, Hou X, Talbott H, Cushman R, Cupp A & Davis JS 2013 ATF3 expression in the 559 
corpus luteum: possible role in luteal regression. Molecular Endocrinology 27 2066–2079. 560 
Maroni D & Davis JS 2011 TGFB1 disrupts the angiogenic potential of microvascular 561 
endothelial cells of the corpus luteum. Journal of Cell Science 124 2501–2510. 562 
Maroni D & Davis JS 2012 Transforming Growth Factor Beta 1 stimulates profibrotic activities 563 
of luteal fibroblasts in cows. Biology of Reproduction 87 1–11. 564 
Mondal M, Schilling B, Folger J, Steibel JP, Buchnick H, Zalman Y, Ireland JJ, Meidan R & 565 
Smith GW 2011 Deciphering the luteal transcriptome: potential mechanisms mediating stage-566 
specific luteolytic response of the corpus luteum to prostaglandin F(2)alpha. Physiological 567 
Genomics 43 447–456. 568 
Page 24 of 40
 Page 25 of 32 
 
Mukaida N 2000 Interleukin-8: an expanding universe beyond neutrophil chemotaxis and 569 
activation. International Journal of Hematology 72 391–398. 570 
Mukaida N 2003 Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. 571 
American Journal of Physiology. Lung Cellular and Molecular Physiology 284 L566–77. 572 
Murdoch WJ 1987 Treatment of sheep with prostaglandin F2 alpha enhances production of a 573 
luteal chemoattractant for eosinophils. American Journal of Reproductive Immunology and 574 
Microbiology 15 52–56. 575 
Murray P & Wynn T 2011 Protective and pathogenic functions of macrophage subsets. Nature 576 
Reviews Immunology 11 723–737. 577 
Neptune ER, Iiri T & Bourne HR 1999 Galphai is not required for chemotaxis mediated by Gi-578 
coupled receptors. The Journal of Biological Chemistry 274 2824–2828. 579 
Niswender GD 2002 Molecular control of luteal secretion of progesterone. Reproduction 123 580 
333–339. 581 
Niswender GD, Davis TL, Griffith RJ, Bogan RL, Monser K, Bott RC, Bruemmer JE & Nett 582 
TM 2007 Judge, jury and executioner: the auto-regulation of luteal function. Society of 583 
Reproduction and Fertility Supplement 64 191–206. 584 
Niswender GD, Juengel JL, Silva PJ, Rollyson MK & McIntush EW 2000 Mechanisms 585 
controlling the function and life span of the corpus luteum. Physiological Reviews 80 1–29. 586 
Nitta A, Shirasuna K, Haneda S, Matsui M, Shimizu T, Matsuyama S, Kimura K, Bollwein H 587 
& Miyamoto A 2011 Possible involvement of IFNT in lymphangiogenesis in the corpus luteum 588 
during the maternal recognition period in the cow. Reproduction 142 879–892. 589 
Page 25 of 40
 Page 26 of 32 
 
Pate JL & Landis Keyes P 2001 Immune cells in the corpus luteum: friends or foes? 590 
Reproduction 122 665–676. 591 
Penny LA, Armstrong D, Bramley TA, Webb R, Collins RA & Watson ED 1999 Immune cells 592 
and cytokine production in the bovine corpus luteum throughout the oestrous cycle and after 593 
induced luteolysis. Journal of Reproduction and Fertility 115 87–96. 594 
Polec A, Tanbo T & Fedorcsak P 2009 Cellular interaction regulates interleukin-8 secretion by 595 
granulosa-lutein cells and monocytes/macrophages. American Journal of Reproductive 596 
Immunology 61 85–94. 597 
Quirk SM, Cowan RG & Harman RM 2013 Role of the cell cycle in regression of the corpus 598 
luteum. Reproduction 145 161–75. 599 
Sales KJ, Maldonado-Perez D, Grant V, Catalano RD, Wilson MR, Brown P, Williams ARW, 600 
Anderson RA, Thompson EA, Jabbour HN & Maldonado-Pérez D 2009 Prostaglandin F 2 α 601 
-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via 602 
the calcium – calcineurin – NFAT pathway. Biochimica et Biophysica Acta - Molecular Cell 603 
Research 1793 1917–1928. 604 
Shimizu T, Imamura E, Magata F, Murayama C & Miyamoto A 2013 Interleukin-8 stimulates 605 
progesterone production via the MEK pathway in ovarian theca cells. Molecular and Cellular 606 
Biochemistry 374 157–161. 607 
Shimizu T, Kaji A, Murayama C, Magata F, Shirasuna K, Wakamiya K, Okuda K & 608 
Miyamoto A 2012 Effects of interleukin-8 on estradiol and progesterone production by bovine 609 
granulosa cells from large follicles and progesterone production by luteinizing granulosa cells in 610 
culture. Cytokine 57 175–181. 611 
Page 26 of 40
 Page 27 of 32 
 
Shirasuna K, Jiemtaweeboon S, Raddatz S, Nitta A, Schuberth HJ, Bollwein H, Shimizu T 612 
& Miyamoto A 2012a Rapid accumulation of polymorphonuclear neutrophils in the corpus 613 
luteum during prostaglandin F(2alpha)-induced luteolysis in the cow. PloS One 7 e29054. 614 
Shirasuna K, Nitta A, Sineenard J, Shimizu T, Bollwein H & Miyamoto A 2012b Vascular 615 
and immune regulation of corpus luteum development, maintenance, and regression in the cow. 616 
Domestic Animal Endocrinology 43 198–211. 617 
Shirasuna K, Shimizu T, Matsui M & Miyamoto A 2012c Emerging roles of immune cells in 618 
luteal angiogenesis. Reproduction, Fertility and Development 25 351–361. 619 
Skarzynski D 2008 Regulation of luteal function and corpus luteum regression in cows: 620 
hormonal control, immune mechanisms and intercellular communication. Reproduction in 621 
Domestic Animals 43 57–65. 622 
Skarzynski DJ, Piotrowska KK, Bah MM, Korzekwa A, Woclawek-Potocka I, Sawai K & 623 
Okuda K 2009 Effects of exogenous tumour necrosis factor-alpha on the secretory function of 624 
the bovine reproductive tract depend on tumour necrosis factor-alpha concentrations. 625 
Reproduction in Domestic Animals 44 371–379. 626 
Skarzynski DJ, Piotrowska-Tomala KK, Lukasik K, Galvao A, Farberov S, Zalman Y & 627 
Meidan R 2013 Growth and regression in bovine corpora lutea : regulation by local survival 628 
and death pathways. Reproduction in Domestic Animals 48 25–37. 629 
Stocco C, Telleria C & Gibori G 2007 The molecular control of corpus luteum formation, 630 
function, and regression. Endocrine Reviews 28 117–149. 631 
Page 27 of 40
 Page 28 of 32 
 
Suzuki T, Sasano H, Takaya R, Fukaya T, Yajima a, Date F & Nagura H 1998 Leukocytes in 632 
normal-cycling human ovaries: immunohistochemical distribution and characterization. Human 633 
Reproduction 13 2186–2191. 634 
Ujioka T, Matsukawa A, Tanaka N, Matsuura K, Yoshinaga M & Okamura H 1998 635 
Interleukin-8 as an essential factor in the human chorionic gonadotropin-induced rabbit 636 
ovulatory process: interleukin-8 induces neutrophil accumulation and activation in ovulation. 637 
Biology of Reproduction 58 526–530. 638 
Vinatier D, Dufour P, Tordjeman-Rizzi N, Prolongeau JF, Depret-Moser S & Monnier JC 639 
1995 Immunological aspects of ovarian function: role of the cytokines. European Journal of 640 
Obstetrics & Gynecology and Reproductive Biology 63 155–168. 641 
Walusimbi SS & Pate JL 2013 Physiology and Endocrinology Symposium: Role of immune 642 
cells in the corpus luteum. Journal of Animal Science 91 1650–1659. 643 
Wang LJ, Pascoe V, Petrucco OM & Norman RJ 1992 Distribution of leukocyte  644 
subpopulations in the human corpus luteum. Human Reproduction 7 197–202. 645 
Wiltbank MC & Ottobre JS 2003 Regulation of intraluteal production of prostaglandins. 646 
Reproductive Biology and Endocrinology 2 1–11. 647 
Yadav VK & Medhamurthy R 2006 Dynamic changes in Mitogen-Activated Protein Kinase 648 
activities in the corpus luteum of the Bonnet monkey (Macaca radiata) during development, 649 
induced luteolysis, and simulated early pregnancy: A role for p38 MAPK in the regulation of 650 
luteal function. Endocrinology 147 2018–2027. 651 
Page 28 of 40
 Page 29 of 32 
 
Yadav VK, Sudhagar RR & Medhamurthy R 2002 Apoptosis during spontaneous and 652 
prostaglandin F2a-induced luteal regression in the buffalo cow (Bubalus bubalis): Involvement 653 
of mitogen-activated protein kinases. Biology of Reproduction 67 752–759. 654 
Zhou D, Huang C, Lin Z, Zhan S, Kong L, Fang C & Li J 2014 Macrophage polarization and 655 
function with emphasis on the evolving roles of coordinated regulation of cellular signaling 656 
pathways. Cellular Signalling 26 192–7.  657 
 658 
659 
Page 29 of 40
 Page 30 of 32 
 
Figure legends 660 
Figure 1.  Induction of chemokines following treatment with PGF in vivo and in vitro. 661 
A) Midluteal phase cows were treated with saline or the PGF analogue Lutalyse (25 mg) for up 662 
to 4 h.  Ovaries were surgically removed and RNA was isolated from corpora lutea.  Quantitative 663 
real-time PCR was performed.  Results are shown as means ± SEM, n = 3.  B) To determine 664 
the cellular signaling pathway leading to the induction of IL8 mRNA, bovine steroidogenic luteal 665 
cells were pre-treated for 60 min with vehicle, the ERK1/2 inhibitor U0126 (20 µM), the p38 666 
MAPK inhibitor SB207580 (10 µM) or the JNK inhibitor SP600125 (20 µM).  Luteal cells were 667 
then treated with control media (open bars) or PGF (100 nM, solid bars) for 60 min.  668 
Quantitative real-time PCR for IL8 mRNA was performed.  Results are shown as means ± SEM, 669 
n = 3.  *, P < 0.05;  **, P < 0.01;  ns, not significant .   670 
 671 
Figure 2.  Stimulatory effects of IL8 on neutrophils.  A) Bovine neutrophils were isolated as 672 
described in the Methods.  Shown is an H&E stain of the purified bovine neutrophils used in the 673 
chemotaxis assay.  Neutrophils (105 cells) were placed in the upper chamber of a Boyden 674 
apparatus and control media or IL8 (30 ng/ml) was placed in the lower chamber.  Cell numbers 675 
in the lower chamber were quantified at various intervals.  B) Control media (Control), IL8 (30 676 
ng/ml) or PGF (100 nM) was added to the lower chamber and migration of bovine neutrophils 677 
was determined after 18 h.  Results are shown as means ± SEM, n = 3.  *, P < 0.05, vs Control.  678 
C) Control media (Control), IL8 (30 ng/ml), PGF (100 nM), TNF (10 ng/ml) or TGFB1 (1 ng/ml) 679 
was added to the lower chamber and migration of bovine neutrophils was determined after 3 h.  680 
Results are shown as means ± SEM, n = 4 for CTL, IL8, PGF and n=2 for TNF and TGFB1.  *, 681 
P < 0.05, vs. Control.   682 
 683 
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Figure 3.  IL8 stimulates early signaling responses in bovine neutrophils.  A) Bovine 684 
neutrophils were treated without or with IL8 (30 ng/ml) or TNF (10 ng/ml) for 15 or 120 min to 685 
identify early cell signaling responses.  Western blot analysis was performed using phospho-686 
specific antibodies for ERK, p38 and JNK MAPKs, AKT, and p65 NFκB.  B-actin served as a 687 
loading control.  B) Cells were treated as above and quantitative analysis of phospho-ERK 688 
signaling is shown as means ± SEM, n = 4.   689 
 690 
Figure 4.  IL8 stimulated neutrophil migration is independent of ERK signaling.  A) 691 
Neutrophils were pre-treated for 60 min with vehicle or the ERK1/2 inhibitor U0126 (5 µM) prior 692 
to treatment for 15 or 60 min with IL8 (30 ng/ml).  Western blot analysis was performed for ERK 693 
and phospho-ERK.  B-actin served as a loading control.  B) Neutrophils were placed in a 694 
Boydon chamber and pre-treated for 60 min with vehicle or U0126 (5 µM) prior to treatment with 695 
IL8 (30 ng/ml).  Neutrophil migration was determined after 24 h.  Results are shown as means ± 696 
SEM, n = 3.   697 
 698 
Figure 5.  IL8 and neutrophils do not inhibit luteal progesterone production. A) 699 
Steroidogenic luteal cells were pretreated with increasing amounts of IL8 (0-30 ng/ml) for 30 min 700 
and then treated without (Control) or with LH (10 ng/ml) for 4 h.  Progesterone in the media was 701 
measured by RIA.  Results are shown as means ± SEM, n = 4.  B) Steroidogenic luteal cells 702 
were co-cultured with bovine neutrophils or activated bovine neutrophils as described in the 703 
Methods.  Cells were then treated without (Control) or with LH (10 ng/ml) for 4 h.  Progesterone 704 
in the media was measured by RIA.  Results are shown as means ± SEM, n = 3.  *, P < 0.05, vs 705 
Control; ns, not significant. 706 
 707 
Page 31 of 40
 Page 32 of 32 
 
Figure 6.  Co-cultures of luteal cells with activated peripheral blood mononuclear cells 708 
(PBMCs) inhibit luteal progesterone production. Steroidogenic luteal cells were co-cultured 709 
with bovine PBMCs or activated PBMCs as described in the Methods.  Cells were then treated 710 
without (Control) or with LH (10 ng/ml) for 4 h.  Progesterone in the media was measured by 711 
RIA.  Results are shown as means ± SEM, n = 4.  Bars with different letters are significantly 712 
different, P < 0.05; ns, not significant. 713 
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Table 1. Bovine primers for qPCR. 
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Table 2. Antibodies used for cell signaling, western blots, and flow analysis 
 
Antibody Vendor 
VE-cadherin Pierce Rockford, IL 
StAR Douglas Stocco, PhD Texas Tech Univ 
3β-HSD Ian Mason, PhD Dallas, TX 
P450scc Millipore Danvers, MA 
Prolyl 4-hydroxylase Acris Brisbane, QLD 
Collagen 1 Rockland Monoclonal Gilbertsville, PA 
Phospho ERK1/2 Cell Signaling Danvers, MA 
Phospho p38 Cell Signaling Danvers, MA 
Phospho JNK Santa Cruz Santa Cruz, CA 
Phospho AKT Cell Signaling Danvers, MA 
Phospho P65-NFκB Cell Signaling Danvers, MA 
IκBα Santa Cruz Santa Cruz, CA 
B-Actin Sigma Aldrich St. Louis, MO 
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